Vancomycin Hydrochloride as a Risk Factor for Acute Kidney Injury: A Retrospective Study

Shusuke Uekusa1, Yuki Hanai1, Shinobu Hirayama2

  • 1Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, Funabashi, Japan.

Pharmacology
|August 2, 2023
PubMed
Abstract

Insights

High vancomycin (VCM) levels and concurrent use of tazobactam-piperacillin (TZP) increase the risk of acute kidney injury (AKI). Early monitoring of VCM levels within two days can help reduce AKI incidence.

Area of Science:

  • Pharmacology
  • Nephrology
  • Infectious Diseases

Background:

  • Vancomycin hydrochloride (VCM) is associated with acute kidney injury (AKI), with reported incidence ranging from 5-43%.
  • VCM-induced AKI typically occurs 4-17 days after treatment initiation but can manifest earlier.
  • Identifying early risk factors for VCM-induced AKI is crucial for patient safety.

Purpose of the Study:

  • To investigate risk factors for the development of AKI within two and seven days of VCM administration.
  • To determine the incidence of early-onset VCM-induced AKI.

Main Methods:

  • A retrospective, single-center study included 287 patients receiving VCM therapy from April 2013 to December 2019.
  • AKI was diagnosed using Kidney Disease: Improving Global Outcomes (KDIGO) criteria.
  • Risk factors, including serum VCM trough concentrations and concomitant medications, were analyzed.

Main Results:

  • The incidence of VCM-induced AKI within 7 days was 10.8% (31/286), and within 2 days was 5.9% (15/252).
  • Elevated serum VCM trough concentrations (12.67 μg/mL for AKI within 2 days, 19.03 μg/mL for AKI within 7 days) were identified as a risk factor.
  • Concomitant use of tazobactam-piperacillin (TZP) was also a significant risk factor for VCM-induced AKI.

Conclusions:

  • High serum VCM trough concentrations and concurrent VCM-TZP therapy are independent risk factors for VCM-induced AKI.
  • Avoiding concomitant TZP or intensive renal function monitoring during combined therapy may mitigate AKI risk.
  • Monitoring serum VCM trough concentrations within the first two days of treatment can effectively reduce AKI incidence.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
35
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
32
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
31
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
34
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
119
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
32